🔥 Concentrated Flow (Market Close)
See full theme ranking and leading stocks →
Obesity Treatments (Oral) Stocks and Leader (Korea)
Updated: 2026.10.30 (market close)
The Obesity Treatments (Oral) theme has 8 member stock(s) today, with an average return of -1.2%. The leading stock is 한미약품 (+6.7%, trading value 97,349,530,750).
A theme focused on developing obesity treatments in pill form, which overcomes the limitations of existing injectable formats (GLP-1 class) and dramatically improves convenience of administration. Stock prices react sensitively to clinical data from major global pharmaceutical companies and domestic pharma-tech firms.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 한미약품 | 414,500 | +6.7% | 97,349,530,750 |
| 일동제약 | 12,580 | +0.1% | 6,186,044,850 |
| 대웅제약 | 100,900 | -0.6% | 2,955,514,200 |
| 디앤디파마텍 | 40,800 | -2.2% | 17,784,173,650 |
| 킵스파마 | 5,180 | -2.5% | 229,039,635 |
| 케어젠 | 32,950 | -3.0% | 1,885,737,225 |
| 삼천당제약 | 182,900 | -3.0% | 13,101,571,450 |
| 에이비엘바이오 | 39,000 | -4.9% | 10,048,631,150 |
This page's data is for reference only and is not investment advice. Actual market data may differ.